Baron Global Advantage Fund highlighted stocks like Illumina, Inc. (NASDAQ:ILMN) in the third quarter 2024 investor letter.

Illumina, Inc. (NASDAQ:ILMN) was removed from the index. Year to date, the stock has increased around 8%, underperforming iShares Core S&P Mid-Cap ETF (NYSE:IJH). The provider of DNA sequencing ...

Read Our Latest Stock Analysis on Illumina Illumina Trading Down 0.9 % Illumina stock opened at $143.12 on Wednesday. Illumina, Inc. has a 52-week low of $100.08 and a 52-week high of $156.66. The ...

Formerly head of Illumina’s strategy and market intelligence teams, as well as general manager of its companion diagnostics business, Vaz will also sit on Pleno’s board of directors.

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through ...

In conjunction, Illumina, Super Micro Computer, and Moderna will be removed from the index. The Nasdaq-100 Index, which includes the 100 largest non-financial companies listed on Nasdaq ...

Broken String Biosciences has teamed up with the Francis Crick Institute to conduct research into the role of genome stability in amyotrophic lateral sclerosis (ALS). The aim of the project is to ...

The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available ...

Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Illumina (ILMN) to $180 from $184 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech ...